Hutchmed
Hutchmed Sets Sights on Chinese Approval for Autoimmune Disorder Drug Following Phase 3 Triumph
Anika Sharma
Hutchmed, a prominent pharmaceutical player, is gearing up for a significant move as it readies to submit sovleplenib for regulatory ...
Lonsurf gets a boost from FDA for colorectal cancer, challenging rivals Takeda and Hutchmed
SG Tylor
Source – Taiho Oncology Eight years after initially gaining FDA approval for the treatment of heavily pretreated colorectal cancer, Taiho ...
